Bryan J. McMichael - Aug 7, 2024 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Financial Officer
Signature
/s/ Bryan J. McMichael
Stock symbol
CHRS
Transactions as of
Aug 7, 2024
Transactions value $
$0
Form type
4
Date filed
8/9/2024, 04:11 PM
Previous filing
Jan 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRS Stock Option (Right to Buy) Award $0 +75K $0.00 75K Aug 7, 2024 Common Stock 75K $1.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of August 1, 2024 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.